Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment.

AimThe aim of the study was to detect the genetic predictors of reseponse to haloperidol.BackgroundHaloperidol is a benchmark drug for the pharmacological treatment of schizophrenia, but the genetics of its efficacy is yet to be elucidated.MethodsA genome-wide association analysis was carried out in